Boston Scientific Corporation (BSX)
NYSE · Healthcare
Boston Scientific Corporation EBITDA 2007–2025
Boston Scientific Corporation annual/quarterly ebitda history and growth rate from 2007 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Boston Scientific Corporation ebitda for the quarter ending March 31, 2026 was 1.5 B, a 16.53% increase year-over-year.
- Boston Scientific Corporation ebitda for the twelve months ending March 31, 2026 was 4.5 B.
- Boston Scientific Corporation annual ebitda for 2025 was 5.0 B, a 28.64% increase from 2024.
- Boston Scientific Corporation annual ebitda for 2024 was 3.9 B, a 9.41% increase from 2023.
- Boston Scientific Corporation annual ebitda for 2023 was 3.5 B, a 27.07% increase from 2022.
- Boston Scientific Corporation annual ebitda for 2022 was 2.8 B.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Boston Scientific Corporation EBITDA — FAQ
Boston Scientific Corporation (BSX) ebitda over the last 19 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BSX's ebitda history?
The chart and table above show Boston Scientific Corporation's ebitda by year and by quarter, including the growth rate.